Therapeutic efficacy of 177Lu-CHX-A?-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy

Marcus Kelly; Sze Tng Lee; F T Lee; Fiona Smyth; Ian Davis; Martin W Brechbiel; Andrew M Scott

doi:10.1002/pros.20856

Therapeutic efficacy of 177Lu-CHX-A?-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy

Marcus Kelly, Sze Tng Lee, F T Lee, Fiona Smyth, Ian Davis, Martin W Brechbiel, Andrew M Scott

Eastern Health Clinical School

Research output: Contribution to journal › Article › Research › peer-review

46 Citations (Scopus)

Original language	English
Pages (from-to)	92 - 104
Number of pages	13
Journal	The Prostate
Volume	69
Issue number	1
DOIs	https://doi.org/10.1002/pros.20856
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/pros.20856

Cite this

@article{b9400c5dfb26445784bac342ae978a0f,

title = "Therapeutic efficacy of 177Lu-CHX-A?-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy",

author = "Marcus Kelly and Lee, {Sze Tng} and Lee, {F T} and Fiona Smyth and Ian Davis and Brechbiel, {Martin W} and Scott, {Andrew M}",

year = "2009",

doi = "10.1002/pros.20856",

language = "English",

volume = "69",

pages = "92 -- 104",

journal = "The Prostate",

issn = "0270-4137",

publisher = "John Wiley & Sons",

number = "1",

}

TY - JOUR

T1 - Therapeutic efficacy of 177Lu-CHX-A?-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy

AU - Kelly, Marcus

AU - Lee, Sze Tng

AU - Lee, F T

AU - Smyth, Fiona

AU - Davis, Ian

AU - Brechbiel, Martin W

AU - Scott, Andrew M

PY - 2009

Y1 - 2009

UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597150/pdf/nihms68289.pdf

U2 - 10.1002/pros.20856

DO - 10.1002/pros.20856

M3 - Article

SN - 0270-4137

VL - 69

SP - 92

EP - 104

JO - The Prostate

JF - The Prostate

IS - 1

ER -

Therapeutic efficacy of 177Lu-CHX-A?-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy

UN SDGs

Access to Document

Other files and links

Cite this